- Home
- ATNM vs MGLD Comparison
ATNM vs MGLD Comparison
Compare ATNM & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MGLD
- Stock Information
- Founded
- ATNM 2000
- MGLD 1996
- Country
- ATNM United States
- MGLD United States
- Employees
- ATNM N/A
- MGLD N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MGLD Finance/Investors Services
- Sector
- ATNM Health Care
- MGLD Finance
- Exchange
- ATNM Nasdaq
- MGLD Nasdaq
- Market Cap
- ATNM 46.5M
- MGLD 41.9M
- IPO Year
- ATNM N/A
- MGLD N/A
- Fundamental
- Price
- ATNM $1.61
- MGLD $0.97
- Analyst Decision
- ATNM Strong Buy
- MGLD
- Analyst Count
- ATNM 4
- MGLD 0
- Target Price
- ATNM $8.75
- MGLD N/A
- AVG Volume (30 Days)
- ATNM 1.3M
- MGLD 11.3K
- Earning Date
- ATNM 04-25-2025
- MGLD 05-12-2025
- Dividend Yield
- ATNM N/A
- MGLD N/A
- EPS Growth
- ATNM N/A
- MGLD N/A
- EPS
- ATNM N/A
- MGLD N/A
- Revenue
- ATNM $81,000.00
- MGLD $32,057,000.00
- Revenue This Year
- ATNM $138.42
- MGLD N/A
- Revenue Next Year
- ATNM $16,957.05
- MGLD N/A
- P/E Ratio
- ATNM N/A
- MGLD N/A
- Revenue Growth
- ATNM N/A
- MGLD N/A
- 52 Week Low
- ATNM $1.03
- MGLD $0.85
- 52 Week High
- ATNM $10.24
- MGLD $2.10
- Technical
- Relative Strength Index (RSI)
- ATNM 59.52
- MGLD 49.77
- Support Level
- ATNM $1.66
- MGLD $0.85
- Resistance Level
- ATNM $2.41
- MGLD $0.98
- Average True Range (ATR)
- ATNM 0.22
- MGLD 0.08
- MACD
- ATNM 0.05
- MGLD 0.00
- Stochastic Oscillator
- ATNM 37.60
- MGLD 75.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.